US 7259153
Drug formulation and delivery using crystalline methylated cyclodextrins
granted A61KA61K31/216A61K31/55
Quick answer
US patent 7259153 (Drug formulation and delivery using crystalline methylated cyclodextrins) held by Supernus Pharmaceuticals, Inc. expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/216, A61K31/55, A61K31/64, A61K31/724